radioimmunotherapeutics (Murdoch/INSERM)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Nameradioimmunotherapeutics (Murdoch/INSERM)

Drug Alias NameN/A

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyRadiation-emitting products > Radioactive therapeutic agent

Mechanisms of ActionChelating agents

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New ZealandFrance

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesMurdoch University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitut National De La Sante Et De La Recherche Medicale Murdoch University

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A